T helper type 17 immune response plays an indispensable role for development of iodine-induced autoimmune thyroiditis in nonobese diabetic-H2h4 mice

Endocrinology

Volumn 150, Issue 11, 2009, Pages 5135-5142

  Horie, Ichiro ^a   Abiru, Norio ^a   Nagayama, Yuji ^a   Kuriya, Genpei ^a   Saitoh, Ohki ^a   Ichikawa, Tatsuki ^a   Iwakura, Yoichiro ^b   Eguchi, Katsumi ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DRINKING WATER; GAMMA INTERFERON; INTERLEUKIN 17; IODINE; MESSENGER RNA; THYROGLOBULIN ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE THYROIDITIS; CONTROLLED STUDY; DISEASE SEVERITY; HASHIMOTO DISEASE; IMMUNE RESPONSE; LYMPHOCYTIC INFILTRATION; MORBIDITY; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PHENOTYPE; PRIORITY JOURNAL; TH1 CELL; TH17 CELL; TH2 CELL; THYROID GLAND; WILD TYPE;

ANIMALS; AUTOANTIBODIES; CYTOKINES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; HUMANS; INTERLEUKIN-17; IODINE; MALE; MICE; MICE, INBRED NOD; MICE, KNOCKOUT; T-LYMPHOCYTES, HELPER-INDUCER; TH1 CELLS; THYROIDITIS, AUTOIMMUNE;

EID: 70350306937     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-0434     Document Type: Article

References (42)

1. Braverman LE, Utiger RD 2000 Werner, Ingbar's the thyroid. A fundamental and clinical text. Philadelphia: Lippincott Williams & Wilkins.
2. + nonobese diabetic mice develop insulitis and diabetes. J Exp Med 178:793-803
3. h4 mice. Clin Immunol Immunopathol 81:287-292
4. h4 mice. J Autoimmun 12:157-165
5. + T cells are required for iodine accelerated thyroiditis in NOD mice. Cell Immunol 192:113-121
6. Yu S, Dunn R, Kehry MR, Braley-Mullen H 2008 B cell depletion inhibits spontaneous autoimmune thyroiditis in NOD.H-2h4 mice. J Immunol 180:7706-7713
7. H-17 cells in the circle of immunity and autoimmunity. Nat Immunol 8:345-350
8. H2: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145-173
9. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6:1123-1132
10. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, Wang Y, Hood L, Zhu Z, Tian Q, Dong C 2005 A distinct lineage of CD4 T cells regulates tissue inflammation by producing intereleukin-17. Nat Immunol 6:1133-1141 (Pubitemid 41541791)
11. Komiyama Y, Nakae S, Matsuki T, Nambu A, Ishigame H, Kakuta S, Sudo K, Iwakura Y 2006 IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol 177:566-573 (Pubitemid 43939170)
12. Nakae S, Nambu A, Sudo K, Iwakura Y 2003 Suppression of immune induction of collagen-induced arthritis in IL-17 deficient mice. J Immunol 171:6173-6177 (Pubitemid 37467240)
13. + Th cells that cause autoimmune arthritis. J Exp Med 204:41-47
14. Amadi-Obi A, Yu CR, Liu X, Mahdi RM, Clarke GL, Nussenblatt RB, Gery I, Lee YS, Egwuagu CE 2007 TH17 cells contribute to uveitis and scleritis and are expanded by IL-12 and inhibited by IL-17/STAT1. Nat Med 13:711-718 (Pubitemid 46889754)
15. Luger D, Silver PB, Tang J, Cua D, Chen Z, Iwakura Y, Bowman EP, Sgambellone NM, Chan CC, Caspi RR 2008 Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J Exp Med 205:799-810 (Pubitemid 351549879)
16. Cox CA, Shi G, Yin H, Vistica BP, Wawrousek EF, Chan CC, Gery I 2008 Both Th1 and Th17 are immunopathogenic but differ in other key biological activities. J Immunol 180:7414-7422
17. Nguyen CQ, Hu MH, Li Y, Stewart C, Peck AB 2008 Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjogren syndrome. Arthritis Rheum 58:734-743
18. + monocytes to the draining lymphnodes during the initiation of Th17-dependent B cell-mediated autoimmunity. Eur J Immunol 38:1877-1888
19. + T cell trafficking and development by IFN-γ: mechanism and pathological relevance in psoriasis. J Immunol 181:4733-4741
20. Yu S, Sharp GC, Braley-Mullen H 2002 Dual role for IFN-γ, but not for IL-4, in spontaneous autoimmune thyroiditis on NOD.H-2h4 mice. J Immunol 169:3999-4007
21. Yu S, Medling B, Yagita H, Braley-Mullen H 2001 Characteristics of inflammatory cells in spontaneous autoimmune thyroiditis of NOD.H-2h4 mice. J Autoimmun 16:37-46 (Pubitemid 32174173)
22. Yu S, Sharp GC, Braley-Mullen H 2006 Thyrocytes responding to IFN-γ are essential for development of lymphocytic spontaneous autoimmune thyroiditis and inhibition of thyrocyte hyperplasia. J Immunol 176:1259-1265 (Pubitemid 43099731)
23. Kolls JK, Lindén A 2004 Interleukin-17 and inflammation. Immunity 21:467-476
24. Nakae S, Komiyama Y, Nambu A, Sudo K, Iwase M, Homma I, Sekikawa K, Asano M, Iwakura Y 2002 Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17:375-387 (Pubitemid 35279557)
25. null mice. J Exp Med 184:2049-2053
26. Komiyama Y, Nakae S, Matsuki T, Nambu A, Ishigame H, Kakuta S, Sudo K, Iwakura Y 2006 IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol 177:566-573 (Pubitemid 43939170)
27. h4 mice. J Autoimmun 29:195-202
28. Barin JG, Afanasyeva M, Talor MV, Rose NR, Burek CL, Caturegli P 2003 Thyroid-specific expression of IFN-γ limits experimental autoimmune thyroiditis by suppressing lymphocyte activation in cervical lymph nodes. J Immunol 170:5523-5529 (Pubitemid 36617840)
29. Chen K, Wei Y, Sharp GC, Braley-Mullen H 2007 Decreasing TNF-α results in less fibrosis and earlier resolution of granulomatous experimental autoimmune thyroiditis. J Leukoc Biol 81:306-314 (Pubitemid 46021280)
30. h4 mouse. Clin Exp Immunol 142:251-259
31. Fynn JC, Meroueh C, Snower DP, David CS, Kong YM 2007 Depletion of CD4+CD25+ regulatory T cells exacerbates sodium iodine-induced experimental autoimmune thyroiditis in human leukocyte antigen DR3 (DRB1*0301) transgenic class II-knock-out non-obese diabetic mice. Clin Exp Immunol 147:547-554 (Pubitemid 46208058)
32. Kaufman DL, Tisch R, Sarvetnick N, Chatenoud L, Harrison LC, Haskins K, Quinn A, Sercarz E, Singh B, von Herrath M, Wegmann D, Wen L, Zekzer D 2001 Report from the 1st international NOD mouse T-cell workshop and the follow-up mini-workshop. Diabetes 50:2459-2463 (Pubitemid 33642762)
33. Setoguchi K, Misaki Y, Terauchi Y, Yamauchi T, Kawahata K, Kadowaki T, Yamamoto K 2001 Peroxisome proliferator-activated receptor-γ haploinsufficiency enhances B cell proliferative responses and exacerbates experimentally induced arthritis. J Clin Invest 108:1667-1675 (Pubitemid 33144877)
34. Roesler J, Izquierdo JM, Ryser M, Rösen-Wolff A, Gahr M, Valacarcel J, Lenardo MJ, Zheng L 2005 Haploinsufficiency, rather than the effect of an excessive production of soluble CD95, is the basis for ALPSI a in a family with duplicated 3′ splice site AG in CD95 intron 5 on one allele. Blood 106:1652-1659 (Pubitemid 41208578)
35. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK 2006 Reciprocal development pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:235-238
36. Iwanami K, Matsumoto I, Tanaka-Watanabe Y, Inoue A, Mihara M, Ohsugi Y, Mamura M, Goto D, Ito S, Tsutsumi A, Kishimoto T, Sumida T 2008 Crucial role of the interleukin-6/interleukin-17 cytokine axis in the induction of arthritis by glucose-6-phosphatase isomerase. Arthritis Rheum 58:754-763
37. Lowes MA, Kikuchi T, Fuentes-Duculan J, Cardinale I, Zaba LC, Haider AS, Bowman EP, Krueger JG 2008 Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol 128:1207-1211 (Pubitemid 351543220)
38. Kryczek I, Wei S, Gong W, Shu X, Szeliga W, Vatan L, Chen L, Wang G, Zou W 2008 IFN-γ enables APC to promote memory Th17 and abate Th1 cell development. J Immunol 181:5842-5846
39. Stummvoll GH, DiPaolo RJ, Huter EN, Davidson TS, Glass D, Ward JM, Shevach EM 2008 Th1, Th2, and Th17 effector T cell-induced autoimmune gastritis differs in pathological pattern and in susceptibility to suppression by regulatory T cells. J Immunol 181:1908-1916
40. Kroenke MA, Carlson TJ, Andjelkovic AV, Segal BM 2008 IL-12-and IL23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J Exp Med 205:1535-1541
41. Lubberts E, Joosten LA, Oppers B, van den Bersselaar L, Coenen-de Roo CJ, Kolls JK, Schwarzenberger P, van de Loo FA, van den Berg WB 2001 IL-1-independent role of IL-17 synovial inflammation and joint destruction during collagen-induced arthritis. J Immunol 167:1004-1013 (Pubitemid 32660858)
42. Hofstetter HH, Ibrahim SM, Koczan D, Kruse N, Weishaupt A, Toyka KV, Gold R 2005 Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis. Cell Immunol 237:123-130 (Pubitemid 43117208)